Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons D. Gjaltema

Publicaties

Can 'extrafine' dry powder aerosols improve lung deposition?

Are extra-fine particles from dry powder inhalers likely to improve lung deposition?

Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler

Comparison of the in vitro performance of originator and generic drug-combination dry powder inhalers

Comparative in vitro evaluation of four corticosteroid metered dose inhalers: Consistency of delivered dose and particle size distribution

Air classifier technology (ACT) in dry powder inhalation - Part 3. Design and development of an air classifier family for the Novolizer (R) multi-dose dry powder inhaler

Air classifier technology (ACT) in dry powder inhalation - Part 4. Performance of air classifier technology in the Novolizer (R) multi-dose dry powder inhaler

A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation

Comparative in vitro performance evaluation of the Novopulmon® 200 Novolizer® and Budesonid-ratiopharm® Jethaler: Two novel budesonide dry powder inhalers

Comparative in vitro performance evaluation of the Novopulomr 200 Novolizerr and Budesonid-ratiopharmr Jethaler: two novel budesonide dry powder inhalers

Lees meer